Literature DB >> 30684802

Polymorphisms in gene MMP-2 modify the association of cadmium exposure with hypertension risk.

Weixiang Wu1, Dayang Liu2, Shunli Jiang2, Ke Zhang3, Hao Zhou2, Qing Lu4.   

Abstract

BACKGROUND: Cadmium exposure has been inconsistently related with hypertension. However, epidemiologic data on the genetic susceptibility to the hypertensive effect of cadmium exposure are limited.
OBJECTIVES: We investigated whether the associations between cadmium exposure and hypertension risk differed by genetic polymorphisms in MMPs genes.
METHODS: The present study of 497 hypertension cases and 497 healthy controls was conducted in a Chinese population. Urinary cadmium levels were measured with inductively coupled plasma-mass spectrometer (ICP-MS). Multivariable logistic regression models were analyzed after controlling major confounders.
RESULTS: Within the multivariable logistic regression models, compared with the lowest tertile, the highest tertile of urinary cadmium had a 1.33-fold (95% CI: 1.01, 1.93) increased risk of hypertension. Carriers of rs243865 T allele and rs243866 A allele in MMP-2 were suggested to have increased risks of hypertension. The associations of urinary cadmium with hypertension risk were modified by rs14070 (P-value for interaction = 0.022) and rs7201 (P-value for interaction = 0.009) in gene MMP-2. Positively significant trends for increasing odds of hypertension with cadmium levels were observed among the wild types of rs14070 and rs7201, respectively.
CONCLUSIONS: Increasing urinary cadmium concentrations were positively associated with hypertension risk in a Chinese population, and the associations were modified by polymorphism of rs14070 and rs7201 in gene MMP-2.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cadmium; Genetic polymorphism; Hypertension; Matrix metalloproteinases

Mesh:

Substances:

Year:  2019        PMID: 30684802     DOI: 10.1016/j.envint.2019.01.041

Source DB:  PubMed          Journal:  Environ Int        ISSN: 0160-4120            Impact factor:   9.621


  6 in total

1.  Family History of Hypertension and Cobalt Exposure Synergistically Promote the Prevalence of Hypertension.

Authors:  Cailiang Zhang; Qibing Zeng; Yalan Liu; Zixiu Qin; Leilei Liu; Junyan Tao; Linyuan Zhang; Qianyuan Yang; Juan Lei; Xuejie Tang; Qiaorong Wang; Liubo Zheng; Feng Hong
Journal:  Biol Trace Elem Res       Date:  2021-04-12       Impact factor: 3.738

2.  An updated systematic review on the association between Cd exposure, blood pressure and hypertension.

Authors:  Airton C Martins; Ana Carolina B Almeida Lopes; Mariana R Urbano; Maria de Fatima H Carvalho; Ana Maria R Silva; Alexey A Tinkov; Michael Aschner; Arthur E Mesas; Ellen K Silbergeld; Monica M B Paoliello
Journal:  Ecotoxicol Environ Saf       Date:  2020-11-20       Impact factor: 6.291

3.  Association of Myopia and Genetic Variants of TGFB2-AS1 and TGFBR1 in the TGF-β Signaling Pathway: A Longitudinal Study in Chinese School-Aged Children.

Authors:  Linjie Liu; Juan He; Xiaoyan Lu; Yimin Yuan; Dandan Jiang; Haishao Xiao; Shudan Lin; Liangde Xu; Yanyan Chen
Journal:  Front Cell Dev Biol       Date:  2021-04-28

4.  Impact of MMP2 rs243849 and rs14070 genetic polymorphisms on the ischemic stroke susceptibility in Chinese Shaanxi population.

Authors:  Shilin Li; Shiyao Yang; Xiaobo Zhang; Yu Zhang; Jie Zhang; Xiao Zhang; Weiping Li; Xiaochen Niu; Wenzhen Shi; Gejuan Zhang; Mingze Chang; Ye Tian
Journal:  Front Neurol       Date:  2022-07-25       Impact factor: 4.086

5.  APOE Genetic Polymorphism rs7412 T/T Genotype May Be a Risk Factor for Essential Hypertension among Hakka People in Southern China.

Authors:  Hui Rao; Heming Wu; Zhikang Yu; Qingyan Huang
Journal:  Int J Hypertens       Date:  2022-09-14       Impact factor: 2.434

6.  Polymorphisms in gene MTHFR modify the association between gestational weight gain and adverse birth outcomes.

Authors:  Weixiang Wu; Dan Luo; Xiaolin Ruan; Chunming Gu; Weiming Lu; Kailing Lian; Xiaoping Mu
Journal:  Front Nutr       Date:  2022-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.